
Olymvax Biopharmaceuticals: Net profit in the third quarter was 34.2829 million yuan, a year-on-year increase of 7.22%
Olymvax Biopharmaceuticals announced that its revenue for the third quarter was 201 million yuan, a year-on-year increase of 25.38%; net profit was 34.2829 million yuan, a year-on-year increase of 7.22%. Revenue for the first three quarters was 507 million yuan, a year-on-year increase of 31.11%; net profit was 47.4798 million yuan, a year-on-year increase of 1,079.36%

